نتایج جستجو برای: bcr

تعداد نتایج: 11052  

2014
Kathrin Kläsener Palash C Maity Elias Hobeika Jianying Yang Michael Reth

Binding of antigen to the B cell antigen receptor (BCR) initiates a multitude of events resulting in B cell activation. How the BCR becomes signaling-competent upon antigen binding is still a matter of controversy. Using a high-resolution proximity ligation assay (PLA) to monitor the conformation of the BCR and its interactions with co-receptors at a 10-20 nm resolution, we provide direct evide...

Journal: :Journal of immunology 2006
Jonathan M Irish Debra K Czerwinski Garry P Nolan Ronald Levy

Differences in BCR signaling may govern outcomes as diverse as proliferation and cell death. We profiled BCR signaling kinetics in subsets of primary human B cells using flow cytometry. In the predominant population expressing IgM, BCR cross-linking led to a quick burst of Syk, ERK1/2, and p38 signaling. In contrast, IgG B cells sustained higher per-cell ERK1/2 phosphorylation over time. This d...

Journal: :Cancer research 2006
John S Tokarski John A Newitt Chieh Ying J Chang Janet D Cheng Michael Wittekind Susan E Kiefer Kevin Kish Francis Y F Lee Robert Borzillerri Louis J Lombardo Dianlin Xie Yaqun Zhang Herbert E Klei

Chronic myeloid leukemia (CML) is caused by the constitutively activated tyrosine kinase breakpoint cluster (BCR)-ABL. Current frontline therapy for CML is imatinib, an inhibitor of BCR-ABL. Although imatinib has a high rate of clinical success in early phase CML, treatment resistance is problematic, particularly in later stages of the disease, and is frequently mediated by mutations in BCR-ABL...

Journal: :Blood 1993
R A Mandanas D S Leibowitz K Gharehbaghi T Tauchi G S Burgess K Miyazawa H N Jayaram H S Boswell

The p21 RAS product has been implicated as part of the downstream signaling of certain nonreceptor tyrosine kinase oncogenes and several growth factor receptor-ligand interactions. We have reported that the chronic myelogenous leukemia oncogene p210 bcr-abl transforms a growth-factor-dependent myeloid cell line NFS/N1.H7 to interleukin-3 (IL-3) independence. In these p210 bcr-abl-transformed ce...

Journal: :Blood 2000
T Jonuleit H van der Kuip C Miething H Michels M Hallek J Duyster W E Aulitzky

Chronic myeloid leukemia (CML) is a malignant stem cell disease characterized by an expansion of myeloid progenitor cells expressing the constitutively activated Bcr-Abl kinase. This oncogenic event causes a deregulation of apoptosis and cell cycle progression. Although the molecular mechanisms protecting from apoptosis in CML cells are well characterized, the cell cycle regulatory event is poo...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Davide Rossi Valeria Spina Michaela Cerri Silvia Rasi Clara Deambrogi Lorenzo De Paoli Luca Laurenti Rossana Maffei Francesco Forconi Francesco Bertoni Emanuele Zucca Claudio Agostinelli Antonello Cabras Marco Lucioni Maurizio Martini Michele Magni Silvia Deaglio Marco Ladetto Josep F Nomdedeu Caroline Besson Antonio Ramponi Vincenzo Canzonieri Marco Paulli Roberto Marasca Luigi M Larocca Antonino Carbone Stefano A Pileri Valter Gattei Gianluca Gaidano

PURPOSE Few biological prognosticators are useful for prediction of Richter syndrome (RS), representing the transformation of chronic lymphocytic leukemia (CLL) to aggressive lymphoma. Stereotyped B-cell receptors (BCR) may have prognostic effect in CLL progression. We tested the prognostic effect of stereotyped BCR for predicting RS transformation. EXPERIMENTAL DESIGN The prevalence of stere...

Journal: :Journal of immunology 2010
Bhuvana Katkere Sarah Rosa Adriana Caballero Elizabeth A Repasky James R Drake

BCR-mediated Ag processing and presentation is critical to the initiation and control of a humoral immune response. Trafficking of internalized Ag-BCR complexes to intracellular Ag processing compartments is driven by ubiquitination of the cytoplasmic domain of the BCR. Using a biochemical approach, it is here established that ubiquitinated Ag-BCR complexes are formed via a signaling-dependent ...

Journal: :Blood 2001
R C Zhao Y Jiang C M Verfaillie

Most insights into the molecular mechanisms underlying transformation by the p210(BCR/ABL) oncoprotein are derived from studies in which BCR/ABL cDNA was introduced into hematopoietic or fibroblast cell lines. However, such cell line models may not represent all the features of chronic myelogenous leukemia (CML) caused by additional genetic abnormalities and differences in the biology of cell l...

Journal: :Blood 2008
Linfeng Chen Stefano Monti Przemyslaw Juszczynski John Daley Wen Chen Thomas E Witzig Thomas M Habermann Jeffery L Kutok Margaret A Shipp

The role of B-cell receptor (BCR)-mediated survival signals in diffuse large B-cell lymphoma (DLBCL) remains undefined. Ligand-induced BCR signaling induces receptor oligomerization, Igalpha/beta immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation, and activation of the spleen tyrosine kinase (SYK), which initiates downstream events and amplifies the initial BCR signal. BCRs a...

2014
Theodora S Ross Victoria E Mgbemena

Chronic myelogenous leukemia (CML) requires the BCR/ABL tyrosine kinase for disease onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase inhibitors (TKIs) such as imatinib. Most patients are maintained in a disease-suppressed state on daily TKI therapy for several years and in many cases this treatment prevents progression to the blast phase. If the TKI is di...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید